Zdrowie i gospodarka · 01/03/2006

Microbiology Devices; Reclassification of Hepatitis A Virus Serological Assays; Correction

The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 9, 2006 (71 FR 6677). That document reclassified hepatitis A virus (HAV) serological assays from class III (premarket approval) into class II (special controls). That document inadvertently published with an error. This document corrects the error.